Annual Long Term Debt
$0.00
-$1.14 M-100.00%
31 December 2023
Summary:
Protagonist Therapeutics annual long term debt is currently $0.00, with the most recent change of -$1.14 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$3.66 million (-100.00%). PTGX annual long term debt is now -100.00% below its all-time high of $15.76 million, reached on 31 December 2019.PTGX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$10.86 M
-$116.00 K-1.06%
30 September 2024
Summary:
Protagonist Therapeutics quarterly long term debt is currently $10.86 million, with the most recent change of -$116.00 thousand (-1.06%) on 30 September 2024. Over the past year, it has increased by +$10.86 million (+100.00%). PTGX quarterly long term debt is now -31.10% below its all-time high of $15.76 million, reached on 31 December 2019.PTGX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +100.0% |
| 3 y3 years | -100.0% | +196.8% |
| 5 y5 years | -100.0% | -31.1% |
PTGX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -1.1% | ||
| 5 y | 5 years | -100.0% | -31.1% | ||
| alltime | all time | -100.0% | -31.1% |
Protagonist Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.86 M(-1.1%) |
| June 2024 | - | $10.97 M(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $462.00 K(-59.5%) |
| Dec 2022 | $1.14 M(-68.8%) | $1.14 M(-36.8%) |
| Sept 2022 | - | $1.80 M(-26.2%) |
| June 2022 | - | $2.45 M(-20.1%) |
| Mar 2022 | - | $3.06 M(-16.3%) |
| Dec 2021 | $3.66 M | $3.66 M(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $4.24 M(+14.8%) |
| June 2021 | - | $3.69 M(-10.0%) |
| Mar 2021 | - | $4.10 M(-8.8%) |
| Dec 2020 | $4.50 M(-71.4%) | $4.50 M(-7.9%) |
| Sept 2020 | - | $4.88 M(-7.1%) |
| June 2020 | - | $5.26 M(-66.0%) |
| Mar 2020 | - | $15.45 M(-1.9%) |
| Dec 2019 | $15.76 M(>+9900.0%) | $15.76 M(+150.4%) |
| Sept 2019 | - | $6.29 M(-4.9%) |
| June 2019 | - | $6.62 M(-4.4%) |
| Mar 2019 | - | $6.92 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Protagonist Therapeutics annual long term debt?
- What is the all time high annual long term debt for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly long term debt year-on-year change?
What is Protagonist Therapeutics annual long term debt?
The current annual long term debt of PTGX is $0.00
What is the all time high annual long term debt for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual long term debt is $15.76 M
What is Protagonist Therapeutics quarterly long term debt?
The current quarterly long term debt of PTGX is $10.86 M
What is the all time high quarterly long term debt for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly long term debt is $15.76 M
What is Protagonist Therapeutics quarterly long term debt year-on-year change?
Over the past year, PTGX quarterly long term debt has changed by +$10.86 M (+100.00%)